2019
DOI: 10.1016/j.jvs.2018.08.176
|View full text |Cite
|
Sign up to set email alerts
|

Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
1
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 26 publications
0
10
1
1
Order By: Relevance
“…Patients classified as TASC D, mainly female diabetics, with recurrent lesions or chronic total occlusion, are at increased risk of restenosis 33 . Other authors have also demonstrated worse prognosis and lower flow rates in patients with TASC degrees C and D 34,35 .…”
Section: Endovascular Treatment Of Femoral Obstructivementioning
confidence: 91%
See 1 more Smart Citation
“…Patients classified as TASC D, mainly female diabetics, with recurrent lesions or chronic total occlusion, are at increased risk of restenosis 33 . Other authors have also demonstrated worse prognosis and lower flow rates in patients with TASC degrees C and D 34,35 .…”
Section: Endovascular Treatment Of Femoral Obstructivementioning
confidence: 91%
“…Although some studies have reported worse prognosis for females 33,34 respectively. This shows that with larger coverage areas, fractures would also be more likely 13 .…”
Section: Endovascular Treatment Of Femoral Obstructivementioning
confidence: 95%
“…Clinical diagnosis of PAD refers to the guideline [4], and the severity of the diseases was based on fontaine stages. The inclusion criteria were as following: age >60 years; chronic total occlusion length of common femoral artery and superficial femoral artery >20 cm, involving popliteal artery [5] at least one inferior genicular artery was unobstructed (stenosis rate <30%), proximal end of occluded segment was unobstructed (stenosis rate <30%). Exclusion criteria were as following: contrast media allergy, antiplatelet and anticoagulant contraindications, previous interventional therapy of target vessels, arterial thrombosis, and thromboangiitis obliterans.…”
Section: Patientsmentioning
confidence: 99%
“…Surgery is the first choice for severe PAD patients. For the choice of treatment strategy, patients with life expectancy >2 years underwent vessels suggested open surgery for TASC II D femoropopliteal arterial disease [4,5]. In addition, with the development of interventional material technology in recent years, endovascular therapies has been widely used in the operation of TASCII D lesions, and have achieved good clinical results [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…3 To facilitate the choice of best method of treatment for symptomatic PAD, the Trans-Atlantic Inter-Society Consensus (TASC) II re-defined class D femoropopliteal lesions as long, chronic total occlusion (CTO) suggesting the need for open surgical revascularisation. 4,5 However, patients presenting CLI usually have poor physical fitness and are at high-risk for open surgery. Additionally in recent years, with the accumulation of clinicians' experience and technical and material advances, endovascular therapy (EVT) of complex, longer lesions of the lower limbs has become commonplace, 6 and have achieved good clinical results with TASC II D femoropopliteal lesions.…”
Section: Introductionmentioning
confidence: 99%